Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [31] Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater
    Kapp, Markus
    Kosmala, Aleksander
    Kircher, Stefan
    Luber, Verena
    Kunzmann, Volker
    CASE REPORTS IN ONCOLOGY, 2016, 9 (01): : 15 - 24
  • [32] Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer
    Hoffman, Robert M.
    Bouvet, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 943 - 947
  • [33] Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells
    Vallo, Stefan
    Koepp, Raoul
    Michaelis, Martin
    Rothweiler, Florian
    Bartsch, Georg
    Brandt, Maximilian P.
    Gust, Kilian M.
    Wezel, Felix
    Blaheta, Roman A.
    Haferkamp, Axel
    Cinatl, Jindrich, Jr.
    ONCOLOGY LETTERS, 2017, 13 (06) : 4085 - 4092
  • [34] Efficacy and safety of nanoparticle albumin-bound paclitaxel compared with solvent-based paclitaxel in adjuvant therapy for breast cancer: A retrospective study
    Lv, Huina
    Hong, Yanyan
    Zhang, Yuting
    Li, Siyu
    Li, Bingbing
    Zhang, Mingjun
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [35] A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer
    Yardley, Denise
    Burris, Howard, III
    Peacock, Nancy
    Raefsky, Eric
    Melnik, Marianne
    Inhorn, Roger
    Shipley, Dianna
    Hainsworth, John
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 471 - 475
  • [36] Potentially Overestimated Efficacy of Nanoparticle Albumin-bound Paclitaxel compared with Solvent-based Paclitaxel in Breast Cancer: A Systemic Review and Meta-analysis
    Li, Bing-Xue
    Chen, Xin-Jie
    Ding, Tong-Jing
    Liu, Yi-Hua
    Ma, Ting-Ting
    Zhang, Gan-Lin
    Wang, Xiao-Min
    JOURNAL OF CANCER, 2021, 12 (17): : 5164 - 5172
  • [37] Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
    Fabi, Alessandra
    Giannarelli, Diana
    Malaguti, Paola
    Ferretti, Gianluigi
    Vari, Sabrina
    Papaldo, Paola
    Nistico, Cecilia
    Caterino, Mauro
    De Vita, Roy
    Mottolese, Marcella
    Iacorossi, Laura
    Cognetti, Francesco
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 6177 - 6183
  • [38] Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review
    Kase, Adam M.
    Azzouqa, Abdel-Ghani
    Kochuveettil, Swapna
    Colon-Otero, Gerardo
    CANCER MEDICINE, 2023, 12 (08): : 9434 - 9438
  • [39] Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
    Shi, Yan
    Qin, Rui
    Wang, Zhi-Kuan
    Dai, Guang-Hai
    ONCOTARGETS AND THERAPY, 2013, 6 : 585 - 591
  • [40] Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
    Fu Siqing
    Culotta, Kirk S.
    Falchook, Gerald S.
    Hong, David S.
    Myers, Alan L.
    Zhang, Yan-Ping
    Naing, Aung
    Janku, Filip
    Hou, Ming-Mo
    Kurzrock, Razelle
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 357 - 364
12345